null

Daratumumab Biosimilar (Anti-CD38) Antibody (HDBS0004)

(No reviews yet) Write a Review
SKU:
HDBS0004
Antibody Type:
Biosimilar Reference Antibody
Applications:
Drug Development
Pharmacokinetics
Disease Area:
Multiple Myeloma
Disease Area:
Leukemia
Protein:
CD38
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
  • Anti-CD38 daratumumab biosimilar mAb HDBS0004
  • Anti-CD38 daratumumab biosimilar mAb HDBS0004
  • Anti-CD38 daratumumab biosimilar mAb HDBS0004
$479

Description

system_update_altDatasheet

Daratumumab (Anti-CD38) Biosimilar Antibody (HDBS0004)

The Anti-CD38 (Daratumumab Biosimilar) Monoclonal Antibody (HDBS0004) is a cutting-edge research tool designed for studying the CD38 protein, a key target in cancer therapy. This antibody, developed as a biosimilar to the monoclonal antibody daratumumab, is highly specific and binds with high affinity to CD38 on human samples. It is validated for use in various applications, including flow cytometry, immunohistochemistry, and ELISA.CD38 is a cell surface protein that plays a crucial role in the regulation of immune responses and is overexpressed in multiple myeloma and other cancers. Targeting CD38 with therapeutic antibodies like daratumumab has shown great promise in treating these malignancies.

This biosimilar antibody provides researchers with a powerful tool for studying the mechanism of action of CD38-targeted therapies and developing new strategies for cancer treatment.With its high specificity and sensitivity, the Anti-CD38 (Daratumumab Biosimilar) Monoclonal Antibody (HDBS0004) is an essential tool for researchers in the fields of oncology, immunology, and drug development. Its ability to bind specifically to CD38 makes it a valuable resource for studying the biology of this important protein and advancing our understanding of cancer immunotherapy.

0 Reviews

View AllClose